Bleeding risk with ischemic stroke therapy - Reply

Simple item page
dc.contributor.authorXian, Y
dc.contributor.authorLiang, L
dc.contributor.authorPeterson, ED
dc.date.accessioned2020-10-27T18:05:58Z
dc.date.available2020-10-27T18:05:58Z
dc.date.issued2012-10-03
dc.date.updated2020-10-27T18:05:58Z
dc.identifier.issn0098-7484
dc.identifier.issn1538-3598
dc.identifier.urihttps://hdl.handle.net/10161/21643
dc.languageen
dc.publisherAmerican Medical Association (AMA)
dc.relation.ispartofJAMA - Journal of the American Medical Association
dc.relation.isversionof10.1001/2012.jama.11667
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectMedicine, General & Internal
dc.subjectGeneral & Internal Medicine
dc.subjectTISSUE-PLASMINOGEN ACTIVATOR
dc.subjectINTRACEREBRAL HEMORRHAGE
dc.subjectTHROMBOLYSIS
dc.titleBleeding risk with ischemic stroke therapy - Reply
dc.typeJournal article
duke.contributor.idXian, Y|0542290
duke.contributor.idPeterson, ED|0130909
duke.contributor.orcidXian, Y|0000-0002-1237-1162
duke.contributor.orcidPeterson, ED|0000-0002-5415-4721
pubs.begin-page1319
pubs.end-page1320
pubs.issue13
pubs.organisational-groupSchool of Medicine
pubs.organisational-groupDuke Clinical Research Institute
pubs.organisational-groupMedicine, Cardiology
pubs.organisational-groupDuke
pubs.organisational-groupInstitutes and Centers
pubs.organisational-groupMedicine
pubs.organisational-groupClinical Science Departments
pubs.organisational-groupNeurology, Neurocritical Care
pubs.organisational-groupMedicine, Clinical Pharmacology
pubs.organisational-groupNeurology
pubs.publication-statusPublished
pubs.volume308

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
letter bleeding risk120134_1319_1320.pdf
Size:
67.63 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Scholarly Articles